Seeking Alpha

EnteroMedics (ETRM -9.1%) is down after closing out its secondary offering of 8.8M common shares...

EnteroMedics (ETRM -9.1%) is down after closing out its secondary offering of 8.8M common shares and 1.76M warrants. It will use the proceeds from the sale to help fund the development of its Maestro RC System, which is used in the treatment of obesity, diabetes and hypertension.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|